People · Operator

Robert C. Dunn

Named in public records as an officer, director or promoter · active 2013–2016 · Other Technology, Biotechnology

2
Companies
2
Filings
$76.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
GS Holdco LLCOther TechnologySeries C$51.0M$1.6B2016
Bioreclamation Holdings, LLCBiotechnologySeries B$25.4M$1.0B2013
Operator network

Robert C. Dunn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Elizabeth R. Borow · 6 companies · 1 sharedElizabeth R. BorowCraig R. Albrecht · 1 companies · 1 sharedCraig R. AlbrechtJesse A. Klein · 1 companies · 1 sharedJesse A. KleinRon Kupferman · 1 companies · 1 sharedRon KupfermanSpencer Kupferman · 1 companies · 1 sharedSpencer KupfermanWilliam L. Willhite · 6 companies · 1 sharedWilliam L. Willhi…Stephen J. Sullivan · 4 companies · 1 sharedStephen J. Sulliv…Clifford Raynor · 1 companies · 1 sharedClifford RaynorHarry Holiday III · 1 companies · 1 sharedHarry Holiday IIIJeffrey Gatz · 1 companies · 1 sharedJeffrey GatzScott Alson · 1 companies · 1 sharedScott AlsonWilliam Tempone · 1 companies · 1 sharedWilliam TemponeGS Holdco LLC · $51.0M raisedGS Holdco LLCBioreclamation Holdings, LLC · $25.4M raisedBioreclamation Holdin…Robert C. DunnRD
Robert C. Dunn Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Robert C. Dunn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
William L. Willhite16
Elizabeth R. Borow16
Stephen J. Sullivan14
Jesse A. Klein11
Spencer Kupferman11
Harry Holiday III11
Scott Alson11
Jeffrey Gatz11
William Tempone11
Clifford Raynor11
Craig R. Albrecht11
Ron Kupferman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.